397 related articles for article (PubMed ID: 24210000)
21. Tumor vasculature: the Achilles' heel of cancer?
Johannessen TC; Wagner M; Straume O; Bjerkvig R; Eikesdal HP
Expert Opin Ther Targets; 2013 Jan; 17(1):7-20. PubMed ID: 23121690
[TBL] [Abstract][Full Text] [Related]
22. Chaotic neovascularization induced by aggressive fibrosarcoma cells overexpressing S-adenosylmethionine decarboxylase.
Paasinen-Sohns A; Kääriäinen E; Yin M; Järvinen K; Nummela P; Hölttä E
Int J Biochem Cell Biol; 2011 Mar; 43(3):441-54. PubMed ID: 21134486
[TBL] [Abstract][Full Text] [Related]
23. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
24. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.
Brem SS; Zagzag D; Tsanaclis AM; Gately S; Elkouby MP; Brien SE
Am J Pathol; 1990 Nov; 137(5):1121-42. PubMed ID: 1700617
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
28. Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells.
Auyeung KK; Woo PK; Law PC; Ko JK
J Ethnopharmacol; 2012 Jun; 141(2):635-41. PubMed ID: 21864667
[TBL] [Abstract][Full Text] [Related]
29. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
Sato Y
Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
[TBL] [Abstract][Full Text] [Related]
30. Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.
Yi EY; Jeong EJ; Song HS; Lee MS; Kang DW; Joo JH; Kwon HS; Lee SH; Park SK; Chung SG; Cho EH; Kim YJ
Int J Oncol; 2004 Aug; 25(2):365-72. PubMed ID: 15254733
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
[TBL] [Abstract][Full Text] [Related]
32. A therapy inactivating the tumor angiogenic factors.
Morales-Rodrigo C
Math Biosci Eng; 2013 Feb; 10(1):185-98. PubMed ID: 23311368
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis.
Roberts DD; Isenberg JS; Ridnour LA; Wink DA
Clin Cancer Res; 2007 Feb; 13(3):795-8. PubMed ID: 17289869
[TBL] [Abstract][Full Text] [Related]
34. A wholly nutritional 'multifocal angiostatic therapy' for control of disseminated cancer.
McCarty MF
Med Hypotheses; 2003 Jul; 61(1):1-15. PubMed ID: 12781633
[TBL] [Abstract][Full Text] [Related]
35. The role of copper in tumour angiogenesis.
Lowndes SA; Harris AL
J Mammary Gland Biol Neoplasia; 2005 Oct; 10(4):299-310. PubMed ID: 16924372
[TBL] [Abstract][Full Text] [Related]
36. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
37. The protection conferred by chelation therapy in post-MI diabetics might be replicated by high-dose zinc supplementation.
McCarty MF; DiNicolantonio JJ
Med Hypotheses; 2015 May; 84(5):451-5. PubMed ID: 25682188
[TBL] [Abstract][Full Text] [Related]
38. Competing pathways of iron chelation: angiogenesis or anti-tumor activity: targeting different molecules to induce specific effects.
Le NT; Richardson DR
Int J Cancer; 2004 Jun; 110(3):468-9. PubMed ID: 15095318
[No Abstract] [Full Text] [Related]
39. Anti-angiogenic alternatives to VEGF blockade.
Khan KA; Bicknell R
Clin Exp Metastasis; 2016 Feb; 33(2):197-210. PubMed ID: 26620208
[TBL] [Abstract][Full Text] [Related]
40. Copper chelation as an antiangiogenic therapy.
Lowndes SA; Harris AL
Oncol Res; 2004; 14(11-12):529-39. PubMed ID: 15666995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
